Mark is an actual patient who has taken COSENTYX and has been compensated for his time.
Indicated for adults only.
Individual results may vary.
Living with ankylosing spondylitis can make simple tasks and activities very challenging—and sometimes even impossible. Stiffness and pain in your back, especially in the morning, can keep you sidelined in your own life, leaving you wondering how to find a way forward.
If you're still struggling with back pain or limited mobility and are considering other treatment options, keep reading to learn more about COSENTYX, and talk to your doctor if you're ready to move on.
COSENTYX is the first medicine of its kind for ankylosing spondylitis (AS). It's the only FDA-approved medication for AS that specifically targets IL-17A.
WHILE THE SPECIFIC CAUSES OF ANKYLOSING SPONDYLITIS ARE NOT FULLY KNOWN, IT IS BELIEVED THAT THERE ARE MULTIPLE PROTEINS IN THE IMMUNE SYSTEM, INCLUDING IL-17A, WHICH MAY PLAY A ROLE IN INFLAMMATION.
COSENTYX is taken once a month*, although your doctor may choose to start you with 5 weekly doses. Work with your doctor to find out what's right for you.
The recommended dose of COSENTYX is 150 mg, which is taken as one injection under the skin. COSENTYX is available in 2 different injection devices—the unique Sensoready® Pen and a prefilled syringe. Make sure to talk to your doctor to find out which one may be a better option for you. You can also see how each device works by watching the demonstration videos.
Your healthcare provider should show you how to prepare and inject COSENTYX before you use it for the first time.
COSENTYX works with or without other therapies, such as methotrexate or sulfasalazine.
*Monthly dose equals 1 dose every 4 weeks.
“I'm feeling very hopeful.”
– MiniSee Mini’s story
Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.
COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:
COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections.
New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn’s disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.
Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; or skin rash. If you have a severe allergic reaction, do not give another injection of COSENTYX.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines to show your doctor and pharmacist when you get a new medicine.
How should I use COSENTYX?
See the detailed Instructions for Use that comes with your COSENTYX for information on how to prepare and inject a dose of COSENTYX, and how to properly throw away (dispose of) used COSENTYX Sensoready® pens and prefilled syringes.
The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory infections. These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
COSENTYX® (secukinumab) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light, alone or with systemic therapy).